CD Protein Inhibitors Immune Checkpoint Inhibitors Immunotherapy Tyrosine Kinase Inhibitors EGFR Other | Non Small Cell Lung Cancer | Lung Non-Squamous Non-Small Cell Cancer | Neuroblastoma | Melanoma |
---|---|---|---|---|
crizotinib | ||||
lorlatinib | ||||
anlotinib | ||||
pembrolizumab | ||||
nivolumab | ||||
ceritinib | ||||
nivolumab + ipilimumab | ||||
crizotinib + alectinib | ||||
TGRX-326 | ||||
sintilimab | ||||
alectinib | ||||
lorlatinib + TNO155 | ||||
EGFR inhibitor | ||||
ALK inhibitor | ||||
Tyrosine kinase inhibitor | ||||
entrectinib | ||||
crizotinib + TNO155 | ||||
ceritinib + TNO155 |